简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
Global Offering
A-Share Analog Chip Leader Goes to Hong Kong: SG Micro Corp (03661.HK) Opens Public Subscription Today
Tags:
SG Micro
IPO
Global Offering
2026-06-17
HJ Science-B (06132.HK) Launches Global Offering at HK$81.80 per Share, Expected to List June 23
Tags:
HJ Science-B
06132.HK
IPO
Global Offering
2026-06-12
Shenzhen Senior Technology (06067.HK) Launches Global Offering at up to HK$8.98 per Share, Expected to List June 23
Tags:
Shenzhen Senior Technology
06067.HK
IPO
Global Offering
2026-06-12
Shenzhen HQVT (01392.HK) Launches Global Offering at HK$7.20 per Share, Expected to List on June 22
Tags:
IPO
Shenzhen HQVT
Global Offering
2026-06-11
Liuliumei (06658.HK): Global Offering of 11,464,100 H Shares, Listing Expected on 15 June
Tags:
Liuliumei
06658.HK
Global Offering
2026-06-05
Featured News
ETF
Csop Ftse Hk-Korea Tech+ Index Etf(03431.HK) Rises 5.74% Intraday with Turnover of HK$56.6191 Million
ETF
Csop Hang Seng China Enterprises Index Daily (2x) Leveraged Product(07288.HK) Rises 6.30% Intraday at HK$2.902
Research
Autonomous Driving Concept Stocks Watch | RoboSense (02498.HK) Edges Up in Morning Session; Second-Generation All-Solid-State Perception Platform E2 Unveiled
Finance
Empowered by HKIC's Patient Capital, Insilico Medicine (3696.HK) Enters $600 Million Global Strategic Partnership with Takeda
Finance
Befar Group(06074.HK): Largest Shareholder Accumulatively Increases Holdings by Approximately 26.38 Million Shares
Finance
Minieye Technology(02431.HK): Proposed H-share Buyback of Up to HK$200 Million
Finance
Xunce (03317.HK): Enters Strategic Cooperation with Xinchen Kechuang
Finance
CanSino Biologics (06185.HK): Supplementary Application for Menhyxin® Accepted, Age Eligibility to Be Expanded to 17 Years Old
Finance
China Wantian Holdings (01854.HK): Enters Strategic Cooperation Framework Agreement with Hengyang Jisuo to Foray into Exoskeleton Robot Sector
Finance
Lee's Pharmaceutical Holdings (00950.HK): Enters Exclusive Licence Agreement with Ashlins for Interferon Alpha-2b for Regions Outside Greater China
Scan QR Code
Download App